As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
At JPMorgan Chase (NYSE:JPM), a filing with the SEC revealed that on Wednesday, Director James S. Crown bought 11,500 shares of JPM, at a cost of $85.48 each, for a total investment of $982,991. JPMorgan Chase is trading off about 0.1% on the day Friday.
And at Aerie Pharmaceuticals (AERI), there was insider buying on Wednesday, by Director Gerald D. Cagle who bought 2,000 shares at a cost of $41.70 each, for a trade totaling $83,400. This purchase marks the first one filed by Cagle in the past twelve months. Aerie Pharmaceuticals is trading down about 0.5% on the day Friday. Cagle was up about 2.2% on the buy at the high point of today's trading session, with AERI trading as high as $42.60 at last check today.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.
Free Email Alerts By Stock:
Launch related slideshow:
